Literature DB >> 14126043

AN EFFECT OF PHENOBARBITONE ON GRISEOFULVIN METABOLISM IN THE RAT.

D BUSFIELD, K J CHILD, E G TOMICH.   

Abstract

Prior administration of phenobarbitone to male and female rats dosed orally or intravenously with griseofulvin caused a fall in blood levels of the antibiotic. The effect of a single oral dose of phenobarbitone was significant after 12 hr and maximal between 12 and 48 hr, and it lasted for at least 96 hr; it was more pronounced when the barbiturate was administered repeatedly. Liver slices from animals dosed with phenobarbitone metabolized griseofulvin more rapidly than did those from undosed animals. The possible relevance of these findings to the clinical use of griseofulvin is discussed.

Entities:  

Keywords:  BLOOD CHEMICAL ANALYSIS; EXPERIMENTAL LAB STUDY; GRISEOFULVIN; LIVER FUNCTION; METABOLISM; PHARMACOLOGY; PHENOBARBITAL; RATS

Mesh:

Substances:

Year:  1964        PMID: 14126043      PMCID: PMC1703912          DOI: 10.1111/j.1476-5381.1964.tb01551.x

Source DB:  PubMed          Journal:  Br J Pharmacol Chemother        ISSN: 0366-0826


  10 in total

1.  The metabolism of griseofulvin in mammals.

Authors:  M J BARNES; B BOOTHROYD
Journal:  Biochem J       Date:  1961-01       Impact factor: 3.857

2.  AN EFFECT OF PHENOBARBITONE ON BLOOD-LEVELS OF GRISEOFULVIN IN MAN.

Authors:  D BUSFIELD; K J CHILD; R M ATKINSON; E G TOMICH
Journal:  Lancet       Date:  1963-11-16       Impact factor: 79.321

3.  Metabolism of ethers in the rabbit. 2. Nuclear-substituted anisoles.

Authors:  H G BRAY; V M CRADDOCK; W V THORPE
Journal:  Biochem J       Date:  1955-06       Impact factor: 3.857

4.  On the metabolism of o-ethoxybenzamide.

Authors:  C DAVISON; J WANGLER; P K SMITH
Journal:  J Pharmacol Exp Ther       Date:  1962-05       Impact factor: 4.030

5.  The influence of sex on the catabolism of griseofulvin.

Authors:  D BUSFIELD; K J CHILD; B BASIL; E G TOMICH
Journal:  J Pharm Pharmacol       Date:  1960-09       Impact factor: 3.765

6.  Adaptive increases in drug-metabolizing enzymes induced by phenobarbital and other drugs.

Authors:  A H CONNEY; C DAVISON; R GASTEL; J J BURNS
Journal:  J Pharmacol Exp Ther       Date:  1960-09       Impact factor: 4.030

7.  Spectrophotofluorometric assay of griseofulvin.

Authors:  C BEDFORD; K J CHILD; E G TOMICH
Journal:  Nature       Date:  1959-08-01       Impact factor: 49.962

8.  Studies on the biological disposition of griseofulvin, an oral antifungal agent.

Authors:  C BEDFORD; D BUSFIELD; K J CHILD; I MACGREGOR; P SUTHERLAND; E G TOMICH
Journal:  Arch Dermatol       Date:  1960-05

9.  The enzymatic conversion of codeine to morphine.

Authors:  J AXELROD
Journal:  J Pharmacol Exp Ther       Date:  1955-11       Impact factor: 4.030

10.  The enzymic cleavage of aromatic ethers.

Authors:  J AXELROD
Journal:  Biochem J       Date:  1956-08       Impact factor: 3.857

  10 in total
  5 in total

1.  Effect of enzyme induction on bioavailability of hetacillin in patients treated with anticonvulsants and chlorpromazine.

Authors:  P Galanopoulou; C Karageorgiou; K Dimakopoulou
Journal:  Eur J Drug Metab Pharmacokinet       Date:  1990 Jan-Mar       Impact factor: 2.441

Review 2.  The interaction of drugs, with particular reference to anaesthetic practice.

Authors:  L C Jenkins
Journal:  Can Anaesth Soc J       Date:  1968-03

3.  Griseofulvin.

Authors: 
Journal:  Br Med J       Date:  1967-12-09

4.  Comparative study of the effects of some inducers with or without protein binding properties on bioavailability of isoxazolylpenicillins in rats.

Authors:  M Couvaris; P Galanopoulou; C Karageorgiou; S Theodosopoulos; D Varonos
Journal:  Eur J Drug Metab Pharmacokinet       Date:  1986 Jul-Sep       Impact factor: 2.441

5.  Bioavailability of hetacillin in rats after liver enzyme induction by various inducers with or without protein binding properties.

Authors:  M Couvaris; P Galanopoulou; C Karageorgiou; H A Jalil; D Varonos
Journal:  Eur J Drug Metab Pharmacokinet       Date:  1985 Jan-Mar       Impact factor: 2.441

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.